Gastroenterology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gastroenterology
Saliva test for esophageal reflux licensed to Bayer
August 7th, 2006
A new saliva test for esophageal reflux disease developed by a Wake Forest University Health Sciences (WFUHS) otolaryngologist has been licensed to Bayer HealthCare's Diagnostics Division by WFUHS. The test, which detects the presence of human pepsin 3b in a patient's saliva, was developed by Jamie Koufman, MD, then professor of otolaryngology at Wake Forest University School of Medicine and director of WFUHS's Center for Voice Disorders. She is now director of the Voice Institute of New York. The test potentially could be used in the offices of primary care physicians and avoid the need for more elaborate and expensive tests. Bayer will market the...
Source: Gastroenterology Week (2006-08-07)
|
